Zivo Operating Cycle from 2010 to 2026

ZIVO Stock  USD 10.10  0.65  6.05%   
Zivo Bioscience Operating Cycle yearly trend continues to be very stable with very little volatility. Operating Cycle is likely to drop to 5.61. During the period from 2010 to 2026, Zivo Bioscience Operating Cycle quarterly data regression pattern had sample variance of  127,158 and median of  49.30. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
5.9
Current Value
5.61
Quarterly Volatility
356.59178788
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Zivo Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zivo Bioscience's main balance sheet or income statement drivers, such as Interest Expense of 25.1 K, Other Operating Expenses of 16.3 M or Total Operating Expenses of 16.2 M, as well as many indicators such as Price To Sales Ratio of 563, Dividend Yield of 0.0 or Days Sales Outstanding of 5.61. Zivo financial statements analysis is a perfect complement when working with Zivo Bioscience Valuation or Volatility modules.
  
Build AI portfolio with Zivo Stock
Check out the analysis of Zivo Bioscience Correlation against competitors.
To learn how to invest in Zivo Stock, please use our How to Invest in Zivo Bioscience guide.
Evaluating Zivo Bioscience's Operating Cycle across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Zivo Bioscience's fundamental strength.

Latest Zivo Bioscience's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Zivo Bioscience over the last few years. It is Zivo Bioscience's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zivo Bioscience's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Zivo Operating Cycle Regression Statistics

Arithmetic Mean127.49
Geometric Mean41.00
Coefficient Of Variation279.71
Mean Deviation162.61
Median49.30
Standard Deviation356.59
Sample Variance127,158
Range1.5K
R-Value(0.44)
Mean Square Error109,688
R-Squared0.19
Significance0.08
Slope(30.89)
Total Sum of Squares2M

Zivo Operating Cycle History

2026 5.61
2025 5.9
2024 5.13
2011 49.3
2010 1509.68

About Zivo Bioscience Financial Statements

Zivo Bioscience investors utilize fundamental indicators, such as Operating Cycle, to predict how Zivo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 5.90  5.61 

Pair Trading with Zivo Bioscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zivo Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will appreciate offsetting losses from the drop in the long position's value.

Moving against Zivo Stock

  0.74KVUE Kenvue Inc Aggressive PushPairCorr
  0.72NATR Natures Sunshine ProductsPairCorr
  0.7HLF Herbalife NutritionPairCorr
  0.59NAII Natural AlternativesPairCorr
  0.53EL Estee Lauder CompaniesPairCorr
The ability to find closely correlated positions to Zivo Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zivo Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Zivo Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Zivo Bioscience to buy it.
The correlation of Zivo Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zivo Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zivo Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Zivo Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Zivo Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zivo Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zivo Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zivo Bioscience Stock:
Check out the analysis of Zivo Bioscience Correlation against competitors.
To learn how to invest in Zivo Stock, please use our How to Invest in Zivo Bioscience guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Will Personal Care Products sector continue expanding? Could Zivo diversify its offerings? Factors like these will boost the valuation of Zivo Bioscience. Anticipated expansion of Zivo directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Zivo Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(2.18)
Revenue Per Share
0.056
Quarterly Revenue Growth
1.083
Return On Assets
(10.02)
Return On Equity
(39.56)
Understanding Zivo Bioscience requires distinguishing between market price and book value, where the latter reflects Zivo's accounting equity. The concept of intrinsic value - what Zivo Bioscience's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Zivo Bioscience's price substantially above or below its fundamental value.
Please note, there is a significant difference between Zivo Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zivo Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Zivo Bioscience's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.